J. Goldman & CO LP Azur Rx Bio Pharma, Inc. Transaction History

J. Goldman & CO LP

$3.53 Billion
Q4 2024

Shares

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2019 Nov 14, 2019	SELL	N/A	-647,770 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	N/A	69,372 Added 11.99%	647,770 $1.1 Million
Q1 2019 May 14, 2019	BUY	N/A	27,040 Added 4.9%	578,398 $1.4 Million
Q4 2018 Feb 14, 2019	BUY	N/A	126,000 Added 29.62%	551,358 $667,000
Q3 2018 Nov 14, 2018	SELL	N/A	-117,192 Reduced 21.6%	425,358 $1.09 Million
Q2 2018 Aug 14, 2018	BUY	N/A	452,550 Added 502.83%	542,550 $1.74 Million
Q1 2018 May 15, 2018	SELL	N/A	-104,932 Reduced 53.83%	90,000 $283,000
Q4 2017 Feb 14, 2018	SELL	N/A	-10,225 Reduced 4.98%	194,932 $709,000
Q3 2017 Nov 14, 2017	BUY	N/A	205,157	205,157 $819,000

About AzurRx BioPharma, Inc.

Ticker AZRX
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,575,104
Market Cap $271M

More about AZRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

News

Stay updated on J. Goldman & CO LP with notifications on news.